References
- National Cancer Institute: Surveillance, Epidemiology and End Results ProgramSEER Stat Fact Sheets-Prostate Cancer Available from: http://seer.cancer.gov/statfacts/html/prost.htmlAccessed February 5, 2016
- Centers for Disease Control and PreventionProstate cancer rates by rate and ethnicity Available from: http://www.cdc.gov/cancer/prostate/statistics/race.htmAccessed February 5, 2016
- American Cancer SocietyLifetime probability of dying from prostate cancer Available from: http://www.cancer.org/cancer/cancerbasics/lifetime-probability-of-developing-or-dying-from-cancerAccessed February 5, 2016
- PientaKJEsperPSRisk factors for prostate cancerAnn Intern Med1993118107938038470854
- American Cancer SocietyWhat are the risk factors for prostate cancer Available from: http://www.cancer.org/cancer/prostatecancer/detailedguide/prostate-cancer-risk-factorsAccessed February 5, 2016
- TakslerGBKeatingNLCutlerDMExplaining racial differences in prostate cancer mortalityCancer20121184280428922246942
- ZenkaDAfrican Americans at higher risk for prostate cancer Available from: http://www.pcf.org/site/c.leJRIROrEpH/b.8368629/k.D6C1/African_Americans_At_Higher_Risk_for_Prostate_Cancer.htmAccessed February 5, 2016
- American Urological Association Guidelines on Prostate Cancer: detection of prostate cancer Available from: https://www.auanet.org/education/guidelines/prostate-cancer-detection.cfmAccessed February 5, 2016
- BarryMJClinical practice. Prostate-specific-antigen testing for early diagnosis of prostate cancerN Engl J Med2001344181373137711333995
- DaneshgariFTaylorGDMillerGJCrawfordEDComputer simulation of the probability of detecting low volume carcinoma of the prostate with six random systematic core biopsiesUrology19954546046097716840
- HullGWRabbaniFAbbasFWheelerTMKattanMWScardinoPTCancer control with radical prostatectomy alone in 1,000 consecutive patientsJ Urol200216752853411792912
- US Prevention Services 9,13 ForceProstate cancer screening Available from: http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/prostate-cancer-screeningAccessed February 5, 2016
- MaXWangRLongJBThe cost implications of prostate cancer screening in the Medicare populationCancer201412019610224122801
- National Cancer InstituteCancer costs projected to reach at least $158 billion in 2020 Available from: http://www.cancer.gov/news-events/pressreleases/2011/CostCancer2020Accessed February 5, 2016
- PrenserJRRubinMAWeiJTChinnalyanAMBeyond PSA: the next generation of prostate cancer biomarkersSci Transl Med20124127127rv3
- TosoianJLoebSPSA and beyond: the past, present, and future of investigative biomarkers for prostate cancerScientificWorldJournal2010101919193120890581
- van DuinMvan MarionRVissersKHigh-resolution array comparative genomic hybridization of chromosome arm 8q: evaluation of genetic progression markers for prostate cancerGenes Chromosomes Cancer20054443844916130124
- Aurich-CostaJZamecheckLOligo fluorescence in situ hybridization (Oligo-Fish), a new strategy for enumerating chromosomes in interphase nucleiFertil Steril200788S86
- Aurich-CostaJNgCSelvaggioSCollsPBradleySOligonucleotide (ODN) fluorescence in situ hybridization (Oligo-FISH) and conventional FISH allow enumeration of 24 chromosomes in 6 successive hybridizations performed in a single dayFertil Steril200992S50
- ZhangSZhangHSCordon-CardoCSelection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group-related antigensInt J Cancer19977350569334809
- SokolovaIHallingKCJenkinsRBThe development of multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urineJ Mol Diagn2000211612311229514
- CuiJDeublerDARohrLRChromosome 7 abnormalities in prostate cancer detected by dual-color fluorescence in situ hybridizationCancer Genet Cytogenet199810751609809035
- FrenchMChromosomal biomarkers of genomic instability relevant to cancerDrug Discov Today2007711281137
- MitelmanFJohanssonBMertensFMitelman Database of chromosome aberrations and gene fusions in cancerMitelmanFJohanssonBMertensF Available from: http://cgap.nci.nih.gov/Chromosomes/Mitelman2011Accessed May 24, 2016
- ReddyKSTripodJContemplations on preclinical validation of fluorescence in situ hybridization probe assay for paraffin-embedded tissues in hematologic disordersCancer Genet Cytogenet20081831518474289
- ClooperCPearsonSThe use of confidence or fiducial limits illustrated in the case of the binomialBiometrika193426404413
- RelmHBaleSJBayrak-ToydemirPWorking Group of the American College of Medical Genetics and Genomics Laboratory Quality Assurance CommitteeACMG clinical laboratory standards for next-generation sequencingGenet Med20131573374723887774
- TrockBJBrotzmanMJMangoldLAEvaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsiesBJU Int20121101566222077694
- WeiJTFengZPartinAWCan Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer?J Clin Oncol201432364066407225385735